Regado Biosciences, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2001-01-01
- Employees
- 11
- Market Cap
- -
Safety, Tolerability and PK/PD of RB006 in a Healthy Volunteer SAD
Phase 1
Completed
- Conditions
- Healthy Volunteer
- Interventions
- Drug: Subcutaneous RB006 3.0 mg/kgDrug: Subcutaneous RB006 0.5 mg/kgDrug: Subcutaneous RB006 1.0 mg/kgDrug: Subcutaneous RB006 2.0 mgDrug: Placebo
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2013-06-07
- Lead Sponsor
- Regado Biosciences, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT01872572
- Locations
- 🇺🇸
PPD Development, LP, Austin, Texas, United States
A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI
Phase 3
Terminated
- Conditions
- Coronary Artery Disease
- Interventions
- Drug: pegnivacogin/anivamersenDrug: Bivalirudin
- First Posted Date
- 2013-05-07
- Last Posted Date
- 2014-10-23
- Lead Sponsor
- Regado Biosciences, Inc.
- Target Recruit Count
- 3232
- Registration Number
- NCT01848106
- Locations
- 🇺🇸
Black Hills Cardiovascular Research, Rapid City, South Dakota, United States
A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome
- First Posted Date
- 2009-07-03
- Last Posted Date
- 2012-03-02
- Lead Sponsor
- Regado Biosciences, Inc.
- Target Recruit Count
- 640
- Registration Number
- NCT00932100
- Locations
- 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States
🇺🇸Sinai Hospital of Baltimore, Baltimore, Maryland, United States
🇺🇸Temple University, Philadelphia, Pennsylvania, United States
Feasibility and Safety Study Comparing REG1 Anticoagulation System With Unfractionated Heparin in Elective PCI
Phase 2
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Drug: REG1Drug: Unfractionated Heparin
- First Posted Date
- 2008-07-15
- Last Posted Date
- 2013-05-31
- Lead Sponsor
- Regado Biosciences, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT00715455
- Locations
- 🇺🇸
Black Hills Clinical Research Center, Rapid City, South Dakota, United States
🇺🇸Henry Ford, Detroit, Michigan, United States
🇺🇸The Care Group, LLC, Indianapolis, Indiana, United States
© Copyright 2025. All Rights Reserved by MedPath